ambroxol has been researched along with Fungemia in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Fungemia: The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pulcrano, G | 1 |
| Panellis, D | 1 |
| De Domenico, G | 1 |
| Rossano, F | 1 |
| Catania, MR | 1 |
1 other study available for ambroxol and Fungemia
| Article | Year |
|---|---|
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Micro | 2012 |